Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-08

Clinical Trial Update: A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 pilot study examining pre- and post-surgery mFOLFIRINOX chemotherapy in patients with localized, resectable pancreatic adenocarcinoma; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mFOLFIRINOX

Snippet

Sponsor: Endeavor Health | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-11-08